Cellceutix Settles with Former CEO for $1M

2/15/11

Cellceutix, a Beverly, MA-based developer of drugs for cancer and other diseases, says that the company and its former CEO George Evans have settled a compensation dispute. The company has agreed to buy 4.6 million shares of stock held by Evans, a former Pfizer lawyer, and/or his sons over the past three years for $1 million. In November, the Cellceutix told regulators that Evans sought $1.7 million in back salary and future compensation over a dispute about his pay at the firm.

Next Post

Related Topics

Related Posts

    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. Biotech IPOs Start to Show Some Modest Signs of Life
  2. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. Announcing Xconomy’s Napa Summit: Keeping America Growing
  5. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.